We are live on ! Find out more
CLLS

Cellectis

70 hedge funds and large institutions have $194M invested in Cellectis in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more call options, than puts

Call options by funds: $559K | Put options by funds: $443K

23% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2.11% less ownership

Funds ownership: 35.95%33.84% (-2.1%)

10% less funds holding

Funds holding: 7870 (-8)

23% less capital invested

Capital invested by funds: $253M → $194M (-$58.5M)

62% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 13

Holders
70
Holders Change
-8
Holders Change %
-10.26%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
27
Reduced
22
Closed
13
Calls
$559K
Puts
$443K
Net Calls
+$116K
Net Calls Change
+$423K

CLLS Hedge Fund Activity: Q3 2021 in Review

70 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2021, worth a combined $194M — down 23% from $253M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CLLS and 5 opened new positions — a net loss of 8 holders — while 22 trimmed existing stakes and 27 added.

The largest buyer was Jane Street, opening a new position worth an estimated $2.36M. The largest seller was ARK Investment Management, cutting an estimated $12.1M.

  • 70 institutional investors held Cellectis (CLLS) as of Q3 2021, down from 78 in Q2 2021.
  • Funds reported $194M of Cellectis stock for Q3 2021, down 23% quarter-over-quarter.
  • 5 funds opened new Cellectis positions in Q3 2021 and 13 closed out, a net change of -8 holders.
  • The largest Cellectis buyer in Q3 2021 was Jane Street, an estimated $2.36M added.
  • The largest Cellectis seller in Q3 2021 was ARK Investment Management, an estimated $12.1M sold.

Based on aggregated 13F filings for Q3 2021.